ChatGPT. -What exactly did Brent Ness, CEO of Aclaroin, say—and why is it important?
A statement along the lines of:
"We are pleased with the company's progress in strengthening our financial position, expanding our clinical presence, and advancing Nociscan's adoption."
— It was also noted that the company's cash position and lack of debt provide confidence in funding operations until the end of 2027.⚠️
Stocktwits: "Sufficient funds from share sale until the end of 2027"
The market is reading this:
V Positive signal
🟢No urgent need for a new placement
✅Reduction of retail's main fear—dilution
🟢CEO publicly accepts reputational risk (such words can be very costly if broken)
☝️• For a low-float / short-squeeze
setup, this is GOLD.